The ATF7IP Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population of human embryonic kidney epithelial cells (HEK293T) with targeted disruption of the ATF7IP gene, encoding activating transcription factor 7-interacting protein. This heterogeneous knockout pool enables loss-of-function studies of ATF7IP, a transcriptional corepressor critical for heterochromatin formation and gene silencing. The polyclonal format provides a robust model for interrogating gene function without single-cell cloning, preserving population-level variability for diverse experimental designs.
The HEK293T host cell line is a widely engineered derivative of HEK293 cells, stably expressing the SV40 large T antigen. This modification permits high-copy-number replication of episomal plasmids containing the SV40 origin, making HEK293T an ideal system for recombinant protein expression, lentiviral packaging, and transient transfection assays. Its epithelial origin and rapid growth characteristics further support scalable and reproducible experiments in molecular and cellular biology.
ATF7IP operates as a transcriptional corepressor by recruiting histone methyltransferases, notably SETDB1, to target gene promoters. This interaction facilitates trimethylation of histone H3 at lysine 9 (H3K9me3), a hallmark of compacted heterochromatin and transcriptional repression. ATF7IP is regulated by upstream factors such as ATF4 and ATF7, and it forms complexes with MBD1, NCOR1, and SP1 to silence retrotransposons and repress SP1-mediated transcription. Through these interactions, ATF7IP integrates into chromatin-remodeling machineries, including the NuRD complex, to maintain genomic stability and govern cellular differentiation programs. Its central role in epigenetic silencing links it to pathways dysregulated in cancer and developmental disorders.
In HEK293T cells, disruption of ATF7IP provides a valuable model to dissect epigenetic regulatory mechanisms. The loss of ATF7IP-mediated repression may derepress silenced genomic regions, allowing investigation of retrotransposon activation, altered chromatin states, and downstream transcriptional effects. Given the cell line??s utility in transfection and expression studies, this knockout enables reconstitution experiments and functional rescue assays to validate ATF7IP-dependent pathways. Moreover, the interaction between ATF7IP and corepressor complexes can be probed via co-immunoprecipitation and ChIP-based approaches, elucidating the dynamics of heterochromatin formation in a tractable human cell background.
Researchers can employ these ATF7IP knockout polyclonal cells in a broad array of applications, including functional genomics screens, cancer biology research, and drug target validation. Standard assays such as western blotting and RT-qPCR confirm knockout efficiency and downstream gene expression changes, while RNA-seq and ChIP-qPCR reveal global transcriptional and epigenetic alterations. Protein interaction studies using co-immunoprecipitation and immunofluorescence microscopy further characterize ATF7IP-containing complexes. Additionally, proliferation assays and reporter gene systems assess functional consequences on cell growth and promoter activity. These applications make the ATF7IP knockout a versatile tool for investigating epigenetic silencing and its therapeutic implications. For further technical details, please contact Ascent Research.
